CSL LimitedASX: CSL

Update - Notification of buy-back - CSL

Sep 23, 2026 at 6:22 PM EDT · Issued by CSL Limited via ASX

Filed with ASX · Sep 23, 2026 at 6:22 PM EDT

On 6ix: 6ix.com/news/update-notification-of-buy-back-csl-2

Appendix 3C - Notification of buy-backAppendix 3C - Notification of buy-back1 / 6Announcement SummaryName of entityCSL LIMITEDAnnouncement typeUpdate announcementType of updateDate of this announcement24/9/2026Reason for updateDaily buy-back notificationASX Security code and description of the...

View Attachment

6ix hasn’t read this filing yet.

CSL Limited on 6ix

Earlier from CSL

UK Government Strengthens Vaccine Partnership with CSL Seqirus, Introducing World-First Flu vaccine (aTIVc) and Extending Health Security Pandemic AgreementSep 22
Public Access to ANDEMBRY® (garadacimab) Expands Across Canada for the Prevention of Hereditary Angioedema (HAE) AttacksSep 22
Notice of Meeting and Shareholder Pack 2026Sep 16
Update - Dividend/Distribution - CSLSep 13

Later from CSL

CSL Seqirus Expands U.S. Availability of Influenza Vaccine following Successful Completion of the 2026/27 Manufacturing CampaignSep 29
CSL enters exclusive agreement with Alentis TherapeuticsOct 4
CSL และ Alentis ประกาศความร่วมมือระดับโลก เพื่อพัฒนาและทำการตลาดยา lixudebart สำหรับโรคไตและตับที่พบได้ยากOct 5
CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseasesOct 5
CSL prices US$1.5 billion in Corporate BondsOct 6

All CSL news releases

Follow CSL into a list and get an email when it puts out news.

Follow CSL